Aprea Therapeutics: A Focus on New Targets and Biomarkers in Oncology
Ahead of presentations at the 6th Annual DDR Inhibitors Summit in Boston this week, Oren Gilad, Ph.D., president and CEO...
Read moreAhead of presentations at the 6th Annual DDR Inhibitors Summit in Boston this week, Oren Gilad, Ph.D., president and CEO...
Read moreSponsored by the not-for-profit Uplifting Athletes, the Young Investigators Draft provides $20,000 grants to 10 beginning-career stage research scientists in...
Focused on treating hypertension, Radnor, PA-based Mineralys Therapeutics filed with the SEC for an initial public offering (IPO). Although specifics...
It has been another successful year for PQE Group, a consulting firm in the Life Sciences industry based in Florence...
Leap Therapeutics, headquartered in Cambridge, Mass., acquired New Hope, Pa.-based Flame Biosciences. The primary focus of the merger was for...